Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-21T17:45:57.035Z Has data issue: false hasContentIssue false

14 - Toxoplasma vaccines

Published online by Cambridge University Press:  24 September 2009

J. L. Fishback
Affiliation:
School of Medicine, Depar tment of Pathology & Oncology,The University of Kansas Medical Center, Kansas City, USA
J. K. Frenkel
Affiliation:
1252 Vallecita Drive, Santa Fe, USA
David H. M. Joynson
Affiliation:
Singleton Hospital, Swansea
Tim G. Wreghitt
Affiliation:
Addenbrooke's Hospital, Cambridge
Get access

Summary

Introduction

The rational design of vaccines should be considered within the context of the immunity that naturally develops against the targeted infection. It follows that each specific infection must be viewed in the context of the transmission cycle and epidemiology. The biological attributes of the microbe should be separated as much as possible from those of its hosts, and should be understood in terms of the evolution of the organism.

T. gondii has apparently evolved from a one-host intestinal coccidia of primitive cats. It has become a highly successful and stable two-host parasite. Its sexual cycle, which leads to oocyst production, occurs in the intestine of carnivorous cats, while extra-intestinal tissue cysts exist in the cats' prey. Prey animals that feed on the ground encounter the infectious oocyst stage from cat faeces. Evolution from the one-host primitive T. gondii to the two-host modern T. gondii was made possible by the evolution of the tissue cyst stage. Extension of infection into intermediate hosts with tissue cysts has enabled the transmission back to cats. Indeed, the T. gondii lifecycle has become so dependent upon tissue cysts that the transmission of infection to cats with tissue cysts is more efficient than the direct transmission from cat to cat via oocysts (Dubey & Frenkel 1976).

These facts are important for an understanding of immunity to T. gondii and the design of vaccines. The tissue cyst is an essential part of the evolved natural cycle.

Type
Chapter
Information
Toxoplasmosis
A Comprehensive Clinical Guide
, pp. 360 - 376
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Toxoplasma vaccines
    • By J. L. Fishback, School of Medicine, Depar tment of Pathology & Oncology,The University of Kansas Medical Center, Kansas City, USA, J. K. Frenkel, 1252 Vallecita Drive, Santa Fe, USA
  • Edited by David H. M. Joynson, Singleton Hospital, Swansea, Tim G. Wreghitt, Addenbrooke's Hospital, Cambridge
  • Book: Toxoplasmosis
  • Online publication: 24 September 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511527005.016
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Toxoplasma vaccines
    • By J. L. Fishback, School of Medicine, Depar tment of Pathology & Oncology,The University of Kansas Medical Center, Kansas City, USA, J. K. Frenkel, 1252 Vallecita Drive, Santa Fe, USA
  • Edited by David H. M. Joynson, Singleton Hospital, Swansea, Tim G. Wreghitt, Addenbrooke's Hospital, Cambridge
  • Book: Toxoplasmosis
  • Online publication: 24 September 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511527005.016
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Toxoplasma vaccines
    • By J. L. Fishback, School of Medicine, Depar tment of Pathology & Oncology,The University of Kansas Medical Center, Kansas City, USA, J. K. Frenkel, 1252 Vallecita Drive, Santa Fe, USA
  • Edited by David H. M. Joynson, Singleton Hospital, Swansea, Tim G. Wreghitt, Addenbrooke's Hospital, Cambridge
  • Book: Toxoplasmosis
  • Online publication: 24 September 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511527005.016
Available formats
×